Abstract
Aging is an inevitable consequence of life, and all multicellular organisms undergo a decline in tissue and organ functions as they age. Several well-known risk factors, such as obesity, diabetes, and lack of physical activity that lead to the cardiovascular system, decline and impede the function of vital organs, ultimately limit overall life span. Over recent years, aging research has experienced an unparalleled growth, particularly with the discovery and recognition of genetic pathways and biochemical processes that control to some extent the rate of aging.
In this chapter, we focus on several aspects of stem cell biology and aging, beginning with major cellular hallmarks of aging, endocrine regulation of aging and its impact on stem cell compartment, and mechanisms of increased longevity. We then discuss the role of epigenetic modifications associated with aging and provide an overview on a most recent search of antiaging modalities.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Hayflick L, Moorhead PS (1961) The serial cultivation of human diploid cell strains. Exp Cell Res 25:585–621
Hayflick L (1976) The cell biology of human aging. N Engl J Med 295:1302–1308. https://doi.org/10.1056/NEJM197612022952308
Hayflick L (1980) The cell biology of human aging. Sci Am 242:58–65
Collado M, Blasco MA, Serrano M (2007) Cellular senescence in cancer and aging. Cell 130:223–233. https://doi.org/10.1016/j.cell.2007.07.003
Harley CB, Futcher AB, Greider CW (1990) Telomeres shorten during ageing of human fibroblasts. Nature 345:458–460. https://doi.org/10.1038/345458a0
Blasco MA (2005) Telomeres and human disease: ageing, cancer and beyond. Nat Rev Genet 6:611–622. https://doi.org/10.1038/nrg1656
de Lange T (2005) Shelterin: the protein complex that shapes and safeguards human telomeres. Genes Dev 19:2100–2110. https://doi.org/10.1101/gad.1346005
von Zglinicki T, Martin-Ruiz CM (2005) Telomeres as biomarkers for ageing and age-related diseases. Curr Mol Med 5:197–203
Palm W, de Lange T (2008) How shelterin protects mammalian telomeres. Annu Rev Genet 42:301–334. https://doi.org/10.1146/annurev.genet.41.110306.130350
Lopez-Otin C, Blasco MA, Partridge L, Serrano M, Kroemer G (2013) The hallmarks of aging. Cell 153:1194–1217. https://doi.org/10.1016/j.cell.2013.05.039
Armanios M et al (2009) Short telomeres are sufficient to cause the degenerative defects associated with aging. Am J Hum Genet 85:823–832. https://doi.org/10.1016/j.ajhg.2009.10.028
Hoeijmakers JH (2009) DNA damage, aging, and cancer. N Engl J Med 361:1475–1485. https://doi.org/10.1056/NEJMra0804615
Ratajczak MZ, Bartke A, Darzynkiewicz Z (2017) Prolonged growth hormone/insulin/insulin-like growth factor nutrient response signaling pathway as a silent killer of stem cells and a culprit in aging. Stem Cell Rev 13:443–453. https://doi.org/10.1007/s12015-017-9728-2
Darzynkiewicz Z, Balazs EA (2012) Genome integrity, stem cells and hyaluronan. Aging (Albany NY) 4:78–88. https://doi.org/10.18632/aging.100438
Powers ET, Morimoto RI, Dillin A, Kelly JW, Balch WE (2009) Biological and chemical approaches to diseases of proteostasis deficiency. Annu Rev Biochem 78:959–991. https://doi.org/10.1146/annurev.biochem.052308.114844
Koga H, Kaushik S, Cuervo AM (2011) Protein homeostasis and aging: the importance of exquisite quality control. Ageing Res Rev 10:205–215. https://doi.org/10.1016/j.arr.2010.02.001
Mizushima N, Levine B, Cuervo AM, Klionsky DJ (2008) Autophagy fights disease through cellular self-digestion. Nature 451:1069–1075. https://doi.org/10.1038/nature06639
Hartl FU, Bracher A, Hayer-Hartl M (2011) Molecular chaperones in protein folding and proteostasis. Nature 475:324–332. https://doi.org/10.1038/nature10317
Morrow G, Samson M, Michaud S, Tanguay RM (2004) Overexpression of the small mitochondrial Hsp22 extends Drosophila life span and increases resistance to oxidative stress. FASEB J 18:598–599. https://doi.org/10.1096/fj.03-0860fje
Walker GA, Lithgow GJ (2003) Lifespan extension in C. elegans by a molecular chaperone dependent upon insulin-like signals. Aging Cell 2:131–139. https://doi.org/10.1046/j.1474-9728.2003.00045.x
Min JN et al (2008) CHIP deficiency decreases longevity, with accelerated aging phenotypes accompanied by altered protein quality control. Mol Cell Biol 28:4018–4025. https://doi.org/10.1128/MCB.00296-08
Swindell WR et al (2009) Endocrine regulation of heat shock protein mRNA levels in long-lived dwarf mice. Mech Ageing Dev 130:393–400. https://doi.org/10.1016/j.mad.2009.03.004
Schultz MB, Sinclair DA (2016) When stem cells grow old: phenotypes and mechanisms of stem cell aging. Development 143:3–14. https://doi.org/10.1242/dev.130633
Smith JA, Daniel R (2012) Stem cells and aging: a chicken-or-the-egg issue? Aging Dis 3:260–268
Liu L, Rando TA (2011) Manifestations and mechanisms of stem cell aging. J Cell Biol 193:257–266. https://doi.org/10.1083/jcb.201010131
Linton PJ, Dorshkind K (2004) Age-related changes in lymphocyte development and function. Nat Immunol 5:133–139. https://doi.org/10.1038/ni1033
Beghe C, Wilson A, Ershler WB (2004) Prevalence and outcomes of anemia in geriatrics: a systematic review of the literature. Am J Med 116(Suppl 7A):3S–10S. https://doi.org/10.1016/j.amjmed.2003.12.009
Lichtman MA, Rowe JM (2004) The relationship of patient age to the pathobiology of the clonal myeloid diseases. Semin Oncol 31:185–197
Rossi DJ, Jamieson CH, Weissman IL (2008) Stems cells and the pathways to aging and cancer. Cell 132:681–696. https://doi.org/10.1016/j.cell.2008.01.036
Metcalf D, Moore AS (1971) Embryonic aspects of haemopoiesis. In: Neuberger A, Tatum EL (eds) Frontiers of biology, vol. 24: hematopoietic cells, pp 172–271. North Holland Publishers, Amsterdam
Broxmeyer HE et al (1989) Human umbilical cord blood as a potential source of transplantable hematopoietic stem/progenitor cells. Proc Natl Acad Sci U S A 86:3828–3832. https://doi.org/10.1073/pnas.86.10.3828
Lansdorp PM, Dragowska W, Mayani H (1993) Ontogeny-related changes in proliferative potential of human hematopoietic cells. J Exp Med 178:787–791. https://doi.org/10.1084/jem.178.3.787
Kollman C et al (2001) Donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated donors: the effect of donor age. Blood 98:2043–2051. https://doi.org/10.1182/blood.v98.7.2043
Sudo K, Ema H, Morita Y, Nakauchi H (2000) Age-associated characteristics of murine hematopoietic stem cells. J Exp Med 192:1273–1280. https://doi.org/10.1084/jem.192.9.1273
Rossi DJ et al (2005) Cell intrinsic alterations underlie hematopoietic stem cell aging. Proc Natl Acad Sci U S A 102:9194–9199. https://doi.org/10.1073/pnas.0503280102
Cho RH, Sieburg HB, Muller-Sieburg CE (2008) A new mechanism for the aging of hematopoietic stem cells: aging changes the clonal composition of the stem cell compartment but not individual stem cells. Blood 111:5553–5561. https://doi.org/10.1182/blood-2007-11-123547
Challen GA, Boles NC, Chambers SM, Goodell MA (2010) Distinct hematopoietic stem cell subtypes are differentially regulated by TGF-beta1. Cell Stem Cell 6:265–278. https://doi.org/10.1016/j.stem.2010.02.002
Beerman I et al (2010) Functionally distinct hematopoietic stem cells modulate hematopoietic lineage potential during aging by a mechanism of clonal expansion. Proc Natl Acad Sci U S A 107:5465–5470. https://doi.org/10.1073/pnas.1000834107
Kim M, Moon HB, Spangrude GJ (2003) Major age-related changes of mouse hematopoietic stem/progenitor cells. Ann N Y Acad Sci 996:195–208. https://doi.org/10.1111/j.1749-6632.2003.tb03247.x
Liang Y, Van Zant G, Szilvassy SJ (2005) Effects of aging on the homing and engraftment of murine hematopoietic stem and progenitor cells. Blood 106:1479–1487. https://doi.org/10.1182/blood-2004-11-4282
Signer RA, Montecino-Rodriguez E, Witte ON, McLaughlin J, Dorshkind K (2007) Age-related defects in B lymphopoiesis underlie the myeloid dominance of adult leukemia. Blood 110:1831–1839. https://doi.org/10.1182/blood-2007-01-069401
Eriksson PS et al (1998) Neurogenesis in the adult human hippocampus. Nat Med 4:1313–1317. https://doi.org/10.1038/3305
Kempermann G, Song H, Gage FH (2015) Neurogenesis in the adult Hippocampus. Cold Spring Harb Perspect Biol 7:a018812. https://doi.org/10.1101/cshperspect.a018812
Palmer TD, Takahashi J, Gage FH (1997) The adult rat hippocampus contains primordial neural stem cells. Mol Cell Neurosci 8:389–404. https://doi.org/10.1006/mcne.1996.0595
Andersen B et al (1995) The Ames dwarf gene is required for Pit-1 gene activation. Dev Biol 172:495–503
Kuhn HG, Dickinson-Anson H, Gage FH (1996) Neurogenesis in the dentate gyrus of the adult rat: age-related decrease of neuronal progenitor proliferation. J Neurosci 16:2027–2033
Maslov AY, Barone TA, Plunkett RJ, Pruitt SC (2004) Neural stem cell detection, characterization, and age-related changes in the subventricular zone of mice. J Neurosci 24:1726–1733. https://doi.org/10.1523/JNEUROSCI.4608-03.2004
Seki T, Arai Y (1995) Age-related production of new granule cells in the adult dentate gyrus. Neuroreport 6:2479–2482
Tropepe V, Craig CG, Morshead CM, van der Kooy D (1997) Transforming growth factor-alpha null and senescent mice show decreased neural progenitor cell proliferation in the forebrain subependyma. J Neurosci 17:7850–7859
Bondolfi L, Ermini F, Long JM, Ingram DK, Jucker M (2004) Impact of age and caloric restriction on neurogenesis in the dentate gyrus of C57BL/6 mice. Neurobiol Aging 25:333–340. https://doi.org/10.1016/S0197-4580(03)00083-6
Renault VM et al (2009) FoxO3 regulates neural stem cell homeostasis. Cell Stem Cell 5:527–539. https://doi.org/10.1016/j.stem.2009.09.014
Bailey KJ, Maslov AY, Pruitt SC (2004) Accumulation of mutations and somatic selection in aging neural stem/progenitor cells. Aging Cell 3:391–397. https://doi.org/10.1111/j.1474-9728.2004.00128.x
Molofsky AV et al (2006) Increasing p16INK4a expression decreases forebrain progenitors and neurogenesis during ageing. Nature 443:448–452. https://doi.org/10.1038/nature05091
Nishino J, Kim I, Chada K, Morrison SJ (2008) Hmga2 promotes neural stem cell self-renewal in young but not old mice by reducing p16Ink4a and p19Arf expression. Cell 135:227–239. https://doi.org/10.1016/j.cell.2008.09.017
Murphy CT et al (2003) Genes that act downstream of DAF-16 to influence the lifespan of Caenorhabditis elegans. Nature 424:277–283. https://doi.org/10.1038/nature01789
Lee S, Dong HH (2017) FoxO integration of insulin signaling with glucose and lipid metabolism. J Endocrinol 233:R67–R79. https://doi.org/10.1530/JOE-17-0002
Paik JH et al (2009) FoxOs cooperatively regulate diverse pathways governing neural stem cell homeostasis. Cell Stem Cell 5:540–553. https://doi.org/10.1016/j.stem.2009.09.013
Santo EE, Paik J (2018) FOXO in neural cells and diseases of the nervous system. Curr Top Dev Biol 127:105–118. https://doi.org/10.1016/bs.ctdb.2017.10.002
Willcox BJ et al (2008) FOXO3A genotype is strongly associated with human longevity. Proc Natl Acad Sci U S A 105:13987–13992. https://doi.org/10.1073/pnas.0801030105
Donlon TA, Davy PMC, Willcox BJ (1890) Analysis of FOXO3 gene polymorphisms associated with human longevity. Methods Mol Biol:251–257. https://doi.org/10.1007/978-1-4939-8900-3_21
Flachsbart F et al (2009) Association of FOXO3A variation with human longevity confirmed in German centenarians. Proc Natl Acad Sci U S A 106:2700–2705. https://doi.org/10.1073/pnas.0809594106
van der Flier LG, Clevers H (2009) Stem cells, self-renewal, and differentiation in the intestinal epithelium. Annu Rev Physiol 71:241–260. https://doi.org/10.1146/annurev.physiol.010908.163145
Heath JP (1996) Epithelial cell migration in the intestine. Cell Biol Int 20:139–146. https://doi.org/10.1006/cbir.1996.0018
Booth C, Potten CS (2000) Gut instincts: thoughts on intestinal epithelial stem cells. J Clin Invest 105:1493–1499. https://doi.org/10.1172/JCI10229
Marshman E, Booth C, Potten CS (2002) The intestinal epithelial stem cell. BioEssays 24:91–98. https://doi.org/10.1002/bies.10028
Bjerknes M, Cheng H (2006) Intestinal epithelial stem cells and progenitors. Methods Enzymol 419:337–383. https://doi.org/10.1016/S0076-6879(06)19014-X
Barker N et al (2007) Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature 449:1003–1007. https://doi.org/10.1038/nature06196
van der Flier LG et al (2009) Transcription factor achaete scute-like 2 controls intestinal stem cell fate. Cell 136:903–912. https://doi.org/10.1016/j.cell.2009.01.031
Martin K, Kirkwood TB, Potten CS (1998) Age changes in stem cells of murine small intestinal crypts. Exp Cell Res 241:316–323. https://doi.org/10.1006/excr.1998.4001
Martin K, Potten CS, Roberts SA, Kirkwood TB (1998) Altered stem cell regeneration in irradiated intestinal crypts of senescent mice. J Cell Sci 111(Pt 16):2297–2303
Yatabe Y, Tavare S, Shibata D (2001) Investigating stem cells in human colon by using methylation patterns. Proc Natl Acad Sci U S A 98:10839–10844. https://doi.org/10.1073/pnas.191225998
Kim JY, Siegmund KD, Tavare S, Shibata D (2005) Age-related human small intestine methylation: evidence for stem cell niches. BMC Med 3:10. https://doi.org/10.1186/1741-7015-3-10
Tian D, Mitchell I, Kreeger PK (2016) Quantitative analysis of insulin-like growth factor 2 receptor and insulin-like growth factor binding proteins to identify control mechanisms for insulin-like growth factor 1 receptor phosphorylation. BMC Syst Biol 10:15. https://doi.org/10.1186/s12918-016-0263-6
Yakar S, Adamo ML (2012) Insulin-like growth factor 1 physiology: lessons from mouse models. Endocrinol Metab Clin North Am 41:231–247, v. https://doi.org/10.1016/j.ecl.2012.04.008
Adamo ML, Neuenschwander S, LeRoith D, Roberts CT Jr (1993) Structure, expression, and regulation of the IGF-I gene. Adv Exp Med Biol 343:1–11. https://doi.org/10.1007/978-1-4615-2988-0_1
Frystyk J, Skjaerbaek C, Dinesen B, Orskov H (1994) Free insulin-like growth factors (IGF-I and IGF-II) in human serum. FEBS Lett 348:185–191. https://doi.org/10.1016/0014-5793(94)00602-4
Delaval K, Feil R (2004) Epigenetic regulation of mammalian genomic imprinting. Curr Opin Genet Dev 14:188–195. https://doi.org/10.1016/j.gde.2004.01.005
Reik W, Walter J (2001) Genomic imprinting: parental influence on the genome. Nat Rev Genet 2:21–32. https://doi.org/10.1038/35047554
Werner H, Weinstein D, Bentov I (2008) Similarities and differences between insulin and IGF-I: structures, receptors, and signalling pathways. Arch Physiol Biochem 114:17–22. https://doi.org/10.1080/13813450801900694
Kornfeld S (1992) Structure and function of the mannose 6-phosphate/insulinlike growth factor II receptors. Annu Rev Biochem 61:307–330. https://doi.org/10.1146/annurev.bi.61.070192.001515
Oka Y, Rozek LM, Czech MP (1985) Direct demonstration of rapid insulin-like growth factor II receptor internalization and recycling in rat adipocytes. Insulin stimulates 125I-insulin-like growth factor II degradation by modulating the IGF-II receptor recycling process. J Biol Chem 260:9435–9442
Baxter RC (2014) IGF binding proteins in cancer: mechanistic and clinical insights. Nat Rev Cancer 14:329–341. https://doi.org/10.1038/nrc3720
Baxter RC (2000) Insulin-like growth factor (IGF)-binding proteins: interactions with IGFs and intrinsic bioactivities. Am J Physiol Endocrinol Metab 278:E967–E976. https://doi.org/10.1152/ajpendo.2000.278.6.E967
Mohan S, Baylink DJ (2002) IGF-binding proteins are multifunctional and act via IGF-dependent and -independent mechanisms. J Endocrinol 175:19–31
Wakai K et al (2009) Time spent walking or exercising and blood levels of insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 (IGFBP-3): a large-scale cross-sectional study in the Japan Collaborative Cohort study. Asian Pac J Cancer Prev 10(Suppl):23–27
Forbes K, Westwood M (2008) The IGF axis and placental function. A mini review. Horm Res 69:129–137. https://doi.org/10.1159/000112585
Frystyk J (2005) Aging somatotropic axis: mechanisms and implications of insulin-like growth factor-related binding protein adaptation. Endocrinol Metab Clin North Am 34:865–876, viii. https://doi.org/10.1016/j.ecl.2005.07.001
Junnila RK, List EO, Berryman DE, Murrey JW, Kopchick JJ (2013) The GH/IGF-1 axis in ageing and longevity. Nat Rev Endocrinol 9:366–376. https://doi.org/10.1038/nrendo.2013.67
Moller N, Jorgensen JO (2009) Effects of growth hormone on glucose, lipid, and protein metabolism in human subjects. Endocr Rev 30:152–177. https://doi.org/10.1210/er.2008-0027
Zadik Z, Chalew SA, McCarter RJ Jr, Meistas M, Kowarski AA (1985) The influence of age on the 24-hour integrated concentration of growth hormone in normal individuals. J Clin Endocrinol Metab 60:513–516. https://doi.org/10.1210/jcem-60-3-513
Bartke A (2008) Growth hormone and aging: a challenging controversy. Clin Interv Aging 3:659–665
Snell GD (1929) Dwarf, a new mendelian recessive character of the house mouse. Proc Natl Acad Sci U S A 15:733–734. https://doi.org/10.1073/pnas.15.9.733
Eicher EM, Beamer WG (1980) New mouse dw allele: genetic location and effects on lifespan and growth hormone levels. J Hered 71:187–190. https://doi.org/10.1093/oxfordjournals.jhered.a109344
Li S et al (1990) Dwarf locus mutants lacking three pituitary cell types result from mutations in the POU-domain gene pit-1. Nature 347:528–533. https://doi.org/10.1038/347528a0
Flurkey K, Papaconstantinou J, Harrison DE (2002) The Snell dwarf mutation Pit1(dw) can increase life span in mice. Mech Ageing Dev 123:121–130
Flurkey K, Papaconstantinou J, Miller RA, Harrison DE (2001) Lifespan extension and delayed immune and collagen aging in mutant mice with defects in growth hormone production. Proc Natl Acad Sci U S A 98:6736–6741. https://doi.org/10.1073/pnas.111158898
Fang Q et al (2016) Genetics of combined pituitary hormone deficiency: roadmap into the genome era. Endocr Rev 37:636–675. https://doi.org/10.1210/er.2016-1101
Turton JP et al (2005) Novel mutations within the POU1F1 gene associated with variable combined pituitary hormone deficiency. J Clin Endocrinol Metab 90:4762–4770. https://doi.org/10.1210/jc.2005-0570
Brooks NL et al (2007) Low utilization of circulating glucose after food withdrawal in Snell dwarf mice. J Biol Chem 282:35069–35077. https://doi.org/10.1074/jbc.M700484200
Koks S et al (2016) Mouse models of ageing and their relevance to disease. Mech Ageing Dev 160:41–53. https://doi.org/10.1016/j.mad.2016.10.001
Brown-Borg HM, Borg KE, Meliska CJ, Bartke A (1996) Dwarf mice and the ageing process. Nature 384:33. https://doi.org/10.1038/384033a0
Bartke A, Sun LY, Longo V (2013) Somatotropic signaling: trade-offs between growth, reproductive development, and longevity. Physiol Rev 93:571–598. https://doi.org/10.1152/physrev.00006.2012
Bartke A et al (2001) Extending the lifespan of long-lived mice. Nature 414:412. https://doi.org/10.1038/35106646
Sornson MW et al (1996) Pituitary lineage determination by the Prophet of Pit-1 homeodomain factor defective in Ames dwarfism. Nature 384:327–333. https://doi.org/10.1038/384327a0
Bartke A, Brown-Borg H (2004) Life extension in the dwarf mouse. Curr Top Dev Biol 63:189–225. https://doi.org/10.1016/S0070-2153(04)63006-7
Fluck C et al (1998) Phenotypic variability in familial combined pituitary hormone deficiency caused by a PROP1 gene mutation resulting in the substitution of Arg-->Cys at codon 120 (R120C). J Clin Endocrinol Metab 83:3727–3734. https://doi.org/10.1210/jcem.83.10.5172
Cohen LE, Radovick S, Wondisford FE (1999) Transcription factors and hypopituitarism. Trends Endocrinol Metab 10:326–332
Bartke A (2011) Single-gene mutations and healthy ageing in mammals. Philos Trans R Soc Lond Ser B Biol Sci 366:28–34. https://doi.org/10.1098/rstb.2010.0281
Brown-Borg HM (2011) Handbook of the biology of aging, 7th edn. pp 25–46. Academic press, Cambridge, Massachusetts, USA
Eicher EM, Beamer WG (1976) Inherited ateliotic dwarfism in mice. Characteristics of the mutation, little, on chromosome 6. J Hered 67:87–91. https://doi.org/10.1093/oxfordjournals.jhered.a108682
Godfrey P et al (1993) GHRH receptor of little mice contains a missense mutation in the extracellular domain that disrupts receptor function. Nat Genet 4:227–232. https://doi.org/10.1038/ng0793-227
Donahue LR, Beamer WG (1993) Growth hormone deficiency in ‘little’ mice results in aberrant body composition, reduced insulin-like growth factor-I and insulin-like growth factor-binding protein-3 (IGFBP-3), but does not affect IGFBP-2, −1 or −4. J Endocrinol 136:91–104. https://doi.org/10.1677/joe.0.1360091
Zhou Y et al (1997) A mammalian model for Laron syndrome produced by targeted disruption of the mouse growth hormone receptor/binding protein gene (the Laron mouse). Proc Natl Acad Sci U S A 94:13215–13220. https://doi.org/10.1073/pnas.94.24.13215
Laron Z, Kopchick J (eds) (2011) Laron syndrome – from man to mouse. Springer Academic press, Cambridge, Massachusetts, USA
List EO et al (2011) Endocrine parameters and phenotypes of the growth hormone receptor gene disrupted (GHR−/−) mouse. Endocr Rev 32:356–386. https://doi.org/10.1210/er.2010-0009
Coschigano KT, Clemmons D, Bellush LL, Kopchick JJ (2000) Assessment of growth parameters and life span of GHR/BP gene-disrupted mice. Endocrinology 141:2608–2613. https://doi.org/10.1210/endo.141.7.7586
Coschigano KT et al (2003) Deletion, but not antagonism, of the mouse growth hormone receptor results in severely decreased body weights, insulin, and insulin-like growth factor I levels and increased life span. Endocrinology 144:3799–3810. https://doi.org/10.1210/en.2003-0374
Fundation. M (2013) Latest Mprize winner (online), http://www.mprize.org/?pn=mj mprize record
Fabrizio P, Pozza F, Pletcher SD, Gendron CM, Longo VD (2001) Regulation of longevity and stress resistance by Sch9 in yeast. Science 292:288–290. https://doi.org/10.1126/science.1059497
Fabrizio P et al (2003) SOD2 functions downstream of Sch9 to extend longevity in yeast. Genetics 163:35–46
Fontana L, Partridge L, Longo VD (2010) Extending healthy life span – from yeast to humans. Science 328:321–326. https://doi.org/10.1126/science.1172539
De Benedictis G et al (2000) Does a retrograde response in human aging and longevity exist? Exp Gerontol 35:795–801
Itier JM et al (1998) Imprinted gene in postnatal growth role. Nature 393:125–126. https://doi.org/10.1038/30120
Borras C et al (2011) RasGrf1 deficiency delays aging in mice. Aging (Albany NY) 3:262–276. https://doi.org/10.18632/aging.100279
Kapahi P et al (2004) Regulation of lifespan in Drosophila by modulation of genes in the TOR signaling pathway. Curr Biol 14:885–890. https://doi.org/10.1016/j.cub.2004.03.059
Heintz C et al (2017) Splicing factor 1 modulates dietary restriction and TORC1 pathway longevity in C. elegans. Nature 541:102–106. https://doi.org/10.1038/nature20789
Calvert S et al (2016) A network pharmacology approach reveals new candidate caloric restriction mimetics in C. elegans. Aging Cell 15:256–266. https://doi.org/10.1111/acel.12432
Robida-Stubbs S et al (2012) TOR signaling and rapamycin influence longevity by regulating SKN-1/Nrf and DAF-16/FoxO. Cell Metab 15:713–724. https://doi.org/10.1016/j.cmet.2012.04.007
Lapierre LR, Hansen M (2012) Lessons from C. elegans: signaling pathways for longevity. Trends Endocrinol Metab 23:637–644. https://doi.org/10.1016/j.tem.2012.07.007
Erdogan CS, Hansen BW, Vang O (2016) Are invertebrates relevant models in ageing research? Focus on the effects of rapamycin on TOR. Mech Ageing Dev 153:22–29. https://doi.org/10.1016/j.mad.2015.12.004
Sun X et al (2012) Nutrient-dependent requirement for SOD1 in lifespan extension by protein restriction in Drosophila melanogaster. Aging Cell 11:783–793. https://doi.org/10.1111/j.1474-9726.2012.00842.x
Selman C et al (2009) Ribosomal protein S6 kinase 1 signaling regulates mammalian life span. Science 326:140–144. https://doi.org/10.1126/science.1177221
Fang Y et al (2018) Effects of rapamycin on growth hormone receptor knockout mice. Proc Natl Acad Sci U S A 115:E1495–E1503. https://doi.org/10.1073/pnas.1717065115
Martinez-Cisuelo V et al (2016) Rapamycin reverses age-related increases in mitochondrial ROS production at complex I, oxidative stress, accumulation of mtDNA fragments inside nuclear DNA, and lipofuscin level, and increases autophagy, in the liver of middle-aged mice. Exp Gerontol 83:130–138. https://doi.org/10.1016/j.exger.2016.08.002
Ito TK et al (2017) Hepatic S6K1 partially regulates lifespan of mice with mitochondrial complex I deficiency. Front Genet 8:113. https://doi.org/10.3389/fgene.2017.00113
Liu JP, Baker J, Perkins AS, Robertson EJ, Efstratiadis A (1993) Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r). Cell 75:59–72
Holzenberger M et al (2003) IGF-1 receptor regulates lifespan and resistance to oxidative stress in mice. Nature 421:182–187. https://doi.org/10.1038/nature01298
Bokov AF et al (2011) Does reduced IGF-1R signaling in Igf1r+/− mice alter aging? PLoS One 6:e26891. https://doi.org/10.1371/journal.pone.0026891
Kappeler L et al (2008) Brain IGF-1 receptors control mammalian growth and lifespan through a neuroendocrine mechanism. PLoS Biol 6:e254. https://doi.org/10.1371/journal.pbio.0060254
Swindell WR, Masternak MM, Bartke A (2010) In vivo analysis of gene expression in long-lived mice lacking the pregnancy-associated plasma protein A (PappA) gene. Exp Gerontol 45:366–374. https://doi.org/10.1016/j.exger.2010.02.009
Conover CA, Mason MA, Levine JA, Novak CM (2008) Metabolic consequences of pregnancy-associated plasma protein-A deficiency in mice: exploring possible relationship to the longevity phenotype. J Endocrinol 198:599–605. https://doi.org/10.1677/JOE-08-0179
Vallejo AN et al (2009) Resistance to age-dependent thymic atrophy in long-lived mice that are deficient in pregnancy-associated plasma protein A. Proc Natl Acad Sci U S A 106:11252–11257. https://doi.org/10.1073/pnas.0807025106
Conover CA, Oxvig C (2017) PAPP-A: a promising therapeutic target for healthy longevity. Aging Cell 16:205–209. https://doi.org/10.1111/acel.12564
Lawrence JB et al (1999) The insulin-like growth factor (IGF)-dependent IGF binding protein-4 protease secreted by human fibroblasts is pregnancy-associated plasma protein-A. Proc Natl Acad Sci U S A 96:3149–3153. https://doi.org/10.1073/pnas.96.6.3149
Conover CA et al (2004) Metalloproteinase pregnancy-associated plasma protein A is a critical growth regulatory factor during fetal development. Development 131:1187–1194. https://doi.org/10.1242/dev.00997
Oxvig C (2015) The role of PAPP-A in the IGF system: location, location, location. J Cell Commun Signal 9:177–187. https://doi.org/10.1007/s12079-015-0259-9
Hoeflich A, David R, Hjortebjerg R (2018) Current IGFBP-related biomarker research in cardiovascular disease-we need more structural and functional information in clinical studies. Front Endocrinol (Lausanne) 9:388. https://doi.org/10.3389/fendo.2018.00388
Conover CA et al (2010) Longevity and age-related pathology of mice deficient in pregnancy-associated plasma protein-A. J Gerontol A Biol Sci Med Sci 65:590–599. https://doi.org/10.1093/gerona/glq032
Argente J, Chowen JA, Perez-Jurado LA, Frystyk J, Oxvig C (2017) One level up: abnormal proteolytic regulation of IGF activity plays a role in human pathophysiology. EMBO Mol Med 9:1338–1345. https://doi.org/10.15252/emmm.201707950
White MF, Maron R, Kahn CR (1985) Insulin rapidly stimulates tyrosine phosphorylation of a Mr-185,000 protein in intact cells. Nature 318:183–186. https://doi.org/10.1038/318183a0
Sun XJ et al (1991) Structure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein. Nature 352:73–77. https://doi.org/10.1038/352073a0
Araki E et al (1994) Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene. Nature 372:186–190. https://doi.org/10.1038/372186a0
Sun XJ et al (1995) Role of IRS-2 in insulin and cytokine signalling. Nature 377:173–177. https://doi.org/10.1038/377173a0
Tamemoto H et al (1994) Insulin resistance and growth retardation in mice lacking insulin receptor substrate-1. Nature 372:182–186. https://doi.org/10.1038/372182a0
Selman C, Partridge L, Withers DJ (2011) Replication of extended lifespan phenotype in mice with deletion of insulin receptor substrate 1. PLoS One 6:e16144. https://doi.org/10.1371/journal.pone.0016144
Selman C et al (2008) Evidence for lifespan extension and delayed age-related biomarkers in insulin receptor substrate 1 null mice. FASEB J 22:807–818. https://doi.org/10.1096/fj.07-9261com
Previs SF, Withers DJ, Ren JM, White MF, Shulman GI (2000) Contrasting effects of IRS-1 versus IRS-2 gene disruption on carbohydrate and lipid metabolism in vivo. J Biol Chem 275:38990–38994. https://doi.org/10.1074/jbc.M006490200
Withers DJ et al (1998) Disruption of IRS-2 causes type 2 diabetes in mice. Nature 391:900–904. https://doi.org/10.1038/36116
Houtkooper RH, Williams RW, Auwerx J (2010) Metabolic networks of longevity. Cell 142:9–14. https://doi.org/10.1016/j.cell.2010.06.029
Kenyon CJ (2010) The genetics of ageing. Nature 464:504–512. https://doi.org/10.1038/nature08980
Russell SJ, Kahn CR (2007) Endocrine regulation of ageing. Nat Rev Mol Cell Biol 8:681–691. https://doi.org/10.1038/nrm2234
Barzilai N, Huffman DM, Muzumdar RH, Bartke A (2012) The critical role of metabolic pathways in aging. Diabetes 61:1315–1322. https://doi.org/10.2337/db11-1300
Kenyon C (2010) A pathway that links reproductive status to lifespan in Caenorhabditis elegans. Ann N Y Acad Sci 1204:156–162. https://doi.org/10.1111/j.1749-6632.2010.05640.x
Tatar M, Bartke A, Antebi A (2003) The endocrine regulation of aging by insulin-like signals. Science 299:1346–1351. https://doi.org/10.1126/science.1081447
Hertweck M, Gobel C, Baumeister R (2004) C. elegans SGK-1 is the critical component in the Akt/PKB kinase complex to control stress response and life span. Dev Cell 6:577–588
Kenyon C, Chang J, Gensch E, Rudner A, Tabtiang R (1993) A C. elegans mutant that lives twice as long as wild type. Nature 366:461–464. https://doi.org/10.1038/366461a0
Kimura KD, Tissenbaum HA, Liu Y, Ruvkun G (1997) daf-2, an insulin receptor-like gene that regulates longevity and diapause in Caenorhabditis elegans. Science 277:942–946. https://doi.org/10.1126/science.277.5328.942
Tatar M et al (2001) A mutant Drosophila insulin receptor homolog that extends life-span and impairs neuroendocrine function. Science 292:107–110. https://doi.org/10.1126/science.1057987
Pierce SB et al (2001) Regulation of DAF-2 receptor signaling by human insulin and ins-1, a member of the unusually large and diverse C. elegans insulin gene family. Genes Dev 15:672–686. https://doi.org/10.1101/gad.867301
Ratajczak MZ et al (2011) RasGrf1: genomic imprinting, VSELs, and aging. Aging (Albany NY) 3:692–697. https://doi.org/10.18632/aging.100354
Kenyon C (2005) The plasticity of aging: insights from long-lived mutants. Cell 120:449–460. https://doi.org/10.1016/j.cell.2005.02.002
Lin K, Hsin H, Libina N, Kenyon C (2001) Regulation of the Caenorhabditis elegans longevity protein DAF-16 by insulin/IGF-1 and germline signaling. Nat Genet 28:139–145. https://doi.org/10.1038/88850
Hwangbo DS, Gershman B, Tu MP, Palmer M, Tatar M (2004) Drosophila dFOXO controls lifespan and regulates insulin signalling in brain and fat body. Nature 429:562–566. https://doi.org/10.1038/nature02549
Johnson SC, Rabinovitch PS, Kaeberlein M (2013) mTOR is a key modulator of ageing and age-related disease. Nature 493:338–345. https://doi.org/10.1038/nature11861
Saxton RA, Sabatini DM (2017) mTOR signaling in growth, metabolism, and disease. Cell 169:361–371. https://doi.org/10.1016/j.cell.2017.03.035
Templeman NM, Murphy CT (2018) Regulation of reproduction and longevity by nutrient-sensing pathways. J Cell Biol 217:93–106. https://doi.org/10.1083/jcb.201707168
Vellai T et al (2003) Genetics: influence of TOR kinase on lifespan in C. elegans. Nature 426:620. https://doi.org/10.1038/426620a
Jia K, Chen D, Riddle DL (2004) The TOR pathway interacts with the insulin signaling pathway to regulate C. elegans larval development, metabolism and life span. Development 131:3897–3906. https://doi.org/10.1242/dev.01255
Um SH et al (2004) Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity. Nature 431:200–205. https://doi.org/10.1038/nature02866
Hardie DG (2011) AMP-activated protein kinase: an energy sensor that regulates all aspects of cell function. Genes Dev 25:1895–1908. https://doi.org/10.1101/gad.17420111
Salminen A, Kaarniranta K (2012) AMP-activated protein kinase (AMPK) controls the aging process via an integrated signaling network. Ageing Res Rev 11:230–241. https://doi.org/10.1016/j.arr.2011.12.005
Hardie DG, Schaffer BE, Brunet A (2016) AMPK: an energy-sensing pathway with multiple inputs and outputs. Trends Cell Biol 26:190–201. https://doi.org/10.1016/j.tcb.2015.10.013
Weir HJ et al (2017) Dietary restriction and AMPK increase lifespan via mitochondrial network and peroxisome remodeling. Cell Metab 26:884–896 e885. https://doi.org/10.1016/j.cmet.2017.09.024
Cameron KO, Kurumbail RG (2016) Recent progress in the identification of adenosine monophosphate-activated protein kinase (AMPK) activators. Bioorg Med Chem Lett 26:5139–5148. https://doi.org/10.1016/j.bmcl.2016.09.065
Hardie DG (2013) AMPK: a target for drugs and natural products with effects on both diabetes and cancer. Diabetes 62:2164–2172. https://doi.org/10.2337/db13-0368
Manio MC, Inoue K, Fujitani M, Matsumura S, Fushiki T (2016) Combined pharmacological activation of AMPK and PPARdelta potentiates the effects of exercise in trained mice. Physiol Rep 4. https://doi.org/10.14814/phy2.12625
Martin-Montalvo A et al (2013) Metformin improves healthspan and lifespan in mice. Nat Commun 4:2192. https://doi.org/10.1038/ncomms3192
Cabreiro F et al (2013) Metformin retards aging in C. elegans by altering microbial folate and methionine metabolism. Cell 153:228–239. https://doi.org/10.1016/j.cell.2013.02.035
Onken B, Driscoll M (2010) Metformin induces a dietary restriction-like state and the oxidative stress response to extend C. elegans Healthspan via AMPK, LKB1, and SKN-1. PLoS One 5:e8758. https://doi.org/10.1371/journal.pone.0008758
Derosa G, Maffioli P, Cicero AF (2012) Berberine on metabolic and cardiovascular risk factors: an analysis from preclinical evidences to clinical trials. Expert Opin Biol Ther 12:1113–1124. https://doi.org/10.1517/14712598.2012.704014
Harrison DE et al (2009) Rapamycin fed late in life extends lifespan in genetically heterogeneous mice. Nature 460:392–395. https://doi.org/10.1038/nature08221
Blagosklonny MV (2013) Rapamycin extends life- and health span because it slows aging. Aging (Albany NY) 5:592–598. https://doi.org/10.18632/aging.100591
Bridges HR, Sirvio VA, Agip AN, Hirst J (2016) Molecular features of biguanides required for targeting of mitochondrial respiratory complex I and activation of AMP-kinase. BMC Biol 14:65. https://doi.org/10.1186/s12915-016-0287-9
Houtkooper RH, Pirinen E, Auwerx J (2012) Sirtuins as regulators of metabolism and healthspan. Nat Rev Mol Cell Biol 13:225–238. https://doi.org/10.1038/nrm3293
Haigis MC, Sinclair DA (2010) Mammalian sirtuins: biological insights and disease relevance. Annu Rev Pathol 5:253–295. https://doi.org/10.1146/annurev.pathol.4.110807.092250
Zhong L, Mostoslavsky R (2011) Fine tuning our cellular factories: sirtuins in mitochondrial biology. Cell Metab 13:621–626. https://doi.org/10.1016/j.cmet.2011.05.004
Verdin E, Hirschey MD, Finley LW, Haigis MC (2010) Sirtuin regulation of mitochondria: energy production, apoptosis, and signaling. Trends Biochem Sci 35:669–675. https://doi.org/10.1016/j.tibs.2010.07.003
Canto C, Auwerx J (2012) Targeting sirtuin 1 to improve metabolism: all you need is NAD(+)? Pharmacol Rev 64:166–187. https://doi.org/10.1124/pr.110.003905
Feige JN, Auwerx J (2008) Transcriptional targets of sirtuins in the coordination of mammalian physiology. Curr Opin Cell Biol 20:303–309. https://doi.org/10.1016/j.ceb.2008.03.012
Jing E, Gesta S, Kahn CR (2007) SIRT2 regulates adipocyte differentiation through FoxO1 acetylation/deacetylation. Cell Metab 6:105–114. https://doi.org/10.1016/j.cmet.2007.07.003
North BJ, Marshall BL, Borra MT, Denu JM, Verdin E (2003) The human Sir2 ortholog, SIRT2, is an NAD+-dependent tubulin deacetylase. Mol Cell 11:437–444
Beirowski B et al (2011) Sir-two-homolog 2 (Sirt2) modulates peripheral myelination through polarity protein Par-3/atypical protein kinase C (aPKC) signaling. Proc Natl Acad Sci U S A 108:E952–E961. https://doi.org/10.1073/pnas.1104969108
Someya S et al (2010) Sirt3 mediates reduction of oxidative damage and prevention of age-related hearing loss under caloric restriction. Cell 143:802–812. https://doi.org/10.1016/j.cell.2010.10.002
Qiu X, Brown K, Hirschey MD, Verdin E, Chen D (2010) Calorie restriction reduces oxidative stress by SIRT3-mediated SOD2 activation. Cell Metab 12:662–667. https://doi.org/10.1016/j.cmet.2010.11.015
Jing E et al (2011) Sirtuin-3 (Sirt3) regulates skeletal muscle metabolism and insulin signaling via altered mitochondrial oxidation and reactive oxygen species production. Proc Natl Acad Sci U S A 108:14608–14613. https://doi.org/10.1073/pnas.1111308108
Haigis MC et al (2006) SIRT4 inhibits glutamate dehydrogenase and opposes the effects of calorie restriction in pancreatic beta cells. Cell 126:941–954. https://doi.org/10.1016/j.cell.2006.06.057
Nasrin N et al (2010) SIRT4 regulates fatty acid oxidation and mitochondrial gene expression in liver and muscle cells. J Biol Chem 285:31995–32002. https://doi.org/10.1074/jbc.M110.124164
Nakagawa T, Lomb DJ, Haigis MC, Guarente L (2009) SIRT5 deacetylates carbamoyl phosphate synthetase 1 and regulates the urea cycle. Cell 137:560–570. https://doi.org/10.1016/j.cell.2009.02.026
Mostoslavsky R et al (2006) Genomic instability and aging-like phenotype in the absence of mammalian SIRT6. Cell 124:315–329. https://doi.org/10.1016/j.cell.2005.11.044
Ford E et al (2006) Mammalian Sir2 homolog SIRT7 is an activator of RNA polymerase I transcription. Genes Dev 20:1075–1080. https://doi.org/10.1101/gad.1399706
Kane AE, Sinclair DA (2018) Sirtuins and NAD(+) in the development and treatment of metabolic and cardiovascular diseases. Circ Res 123:868–885. https://doi.org/10.1161/CIRCRESAHA.118.312498
Schemies J, Uciechowska U, Sippl W, Jung M (2010) NAD(+) -dependent histone deacetylases (sirtuins) as novel therapeutic targets. Med Res Rev 30:861–889. https://doi.org/10.1002/med.20178
Bitterman KJ, Medvedik O, Sinclair DA (2003) Longevity regulation in Saccharomyces cerevisiae: linking metabolism, genome stability, and heterochromatin. Microbiol Mol Biol Rev 67:376–399, table of contents. https://doi.org/10.1128/mmbr.67.3.376-399.2003
Rothgiesser KM, Erener S, Waibel S, Luscher B, Hottiger MO (2010) SIRT2 regulates NF-kappaB dependent gene expression through deacetylation of p65 Lys310. J Cell Sci 123:4251–4258. https://doi.org/10.1242/jcs.073783
Huang H, Tindall DJ (2007) Dynamic FoxO transcription factors. J Cell Sci 120:2479–2487. https://doi.org/10.1242/jcs.001222
Bordone L et al (2006) Sirt1 regulates insulin secretion by repressing UCP2 in pancreatic beta cells. PLoS Biol 4:e31. https://doi.org/10.1371/journal.pbio.0040031
Hou X et al (2008) SIRT1 regulates hepatocyte lipid metabolism through activating AMP-activated protein kinase. J Biol Chem 283:20015–20026. https://doi.org/10.1074/jbc.M802187200
Sanokawa-Akakura R, Akakura S, Tabibzadeh S (2016) Replicative senescence in human fibroblasts is delayed by hydrogen sulfide in a NAMPT/SIRT1 dependent manner. PLoS One 11:e0164710. https://doi.org/10.1371/journal.pone.0164710
Romeo-Guitart D et al (2018) SIRT1 activation with neuroheal is neuroprotective but SIRT2 inhibition with AK7 is detrimental for disconnected motoneurons. Cell Death Dis 9:531. https://doi.org/10.1038/s41419-018-0553-6
Watanabe H et al (2018) Sirt2 facilitates hepatic glucose uptake by deacetylating glucokinase regulatory protein. Nat Commun 9:30. https://doi.org/10.1038/s41467-017-02537-6
Kaeberlein M, McVey M, Guarente L (1999) The SIR2/3/4 complex and SIR2 alone promote longevity in Saccharomyces cerevisiae by two different mechanisms. Genes Dev 13:2570–2580. https://doi.org/10.1101/gad.13.19.2570
Berdichevsky A, Viswanathan M, Horvitz HR, Guarente LC (2006) Elegans SIR-2.1 interacts with 14-3-3 proteins to activate DAF-16 and extend life span. Cell 125:1165–1177. https://doi.org/10.1016/j.cell.2006.04.036
Rogina B, Helfand SL (2004) Sir2 mediates longevity in the fly through a pathway related to calorie restriction. Proc Natl Acad Sci U S A 101:15998–16003. https://doi.org/10.1073/pnas.0404184101
Rascon B, Hubbard BP, Sinclair DA, Amdam GV (2012) The lifespan extension effects of resveratrol are conserved in the honey bee and may be driven by a mechanism related to caloric restriction. Aging (Albany NY) 4:499–508. https://doi.org/10.18632/aging.100474
Wang C et al (2013) The effect of resveratrol on lifespan depends on both gender and dietary nutrient composition in Drosophila melanogaster. Age (Dordr) 35:69–81. https://doi.org/10.1007/s11357-011-9332-3
Gehm BD, McAndrews JM, Chien PY, Jameson JL (1997) Resveratrol, a polyphenolic compound found in grapes and wine, is an agonist for the estrogen receptor. Proc Natl Acad Sci U S A 94:14138–14143. https://doi.org/10.1073/pnas.94.25.14138
Chung JH, Manganiello V, Dyck JR (2012) Resveratrol as a calorie restriction mimetic: therapeutic implications. Trends Cell Biol 22:546–554. https://doi.org/10.1016/j.tcb.2012.07.004
Baur JA et al (2006) Resveratrol improves health and survival of mice on a high-calorie diet. Nature 444:337–342. https://doi.org/10.1038/nature05354
Minor RK et al (2011) SRT1720 improves survival and healthspan of obese mice. Sci Rep 1:70. https://doi.org/10.1038/srep00070
Mitchell SJ et al (2014) The SIRT1 activator SRT1720 extends lifespan and improves health of mice fed a standard diet. Cell Rep 6:836–843. https://doi.org/10.1016/j.celrep.2014.01.031
Singh SK et al (2013) Sirt1 ablation promotes stress-induced loss of epigenetic and genomic hematopoietic stem and progenitor cell maintenance. J Exp Med 210:987–1001. https://doi.org/10.1084/jem.20121608
Kucia M et al (2006) A population of very small embryonic-like (VSEL) CXCR4(+)SSEA-1(+)Oct-4+ stem cells identified in adult bone marrow. Leukemia 20:857–869. https://doi.org/10.1038/sj.leu.2404171
Kucia M et al (2007) Morphological and molecular characterization of novel population of CXCR4+ SSEA-4+ Oct-4+ very small embryonic-like cells purified from human cord blood: preliminary report. Leukemia 21:297–303. https://doi.org/10.1038/sj.leu.2404470
Ratajczak MZ et al (2010) Epiblast/germ line hypothesis of cancer development revisited: lesson from the presence of Oct-4+ cells in adult tissues. Stem Cell Rev 6:307–316. https://doi.org/10.1007/s12015-010-9143-4
Shin DM et al (2010) Molecular signature of adult bone marrow-purified very small embryonic-like stem cells supports their developmental epiblast/germ line origin. Leukemia 24:1450–1461. https://doi.org/10.1038/leu.2010.121
Shin DM et al (2010) Molecular characterization of isolated from murine adult tissues very small embryonic/epiblast like stem cells (VSELs). Mol Cells 29:533–538. https://doi.org/10.1007/s10059-010-0081-4
Shin DM et al (2012) Global gene expression analysis of very small embryonic-like stem cells reveals that the Ezh2-dependent bivalent domain mechanism contributes to their pluripotent state. Stem Cells Dev 21:1639–1652. https://doi.org/10.1089/scd.2011.0389
Shin DM et al (2009) Novel epigenetic mechanisms that control pluripotency and quiescence of adult bone marrow-derived Oct4(+) very small embryonic-like stem cells. Leukemia 23:2042–2051. https://doi.org/10.1038/leu.2009.153
Ratajczak MZ, Shin DM, Schneider G, Ratajczak J, Kucia M (2013) Parental imprinting regulates insulin-like growth factor signaling: a Rosetta stone for understanding the biology of pluripotent stem cells, aging and cancerogenesis. Leukemia 27:773–779. https://doi.org/10.1038/leu.2012.322
Yamazaki Y et al (2003) Reprogramming of primordial germ cells begins before migration into the genital ridge, making these cells inadequate donors for reproductive cloning. Proc Natl Acad Sci U S A 100:12207–12212. https://doi.org/10.1073/pnas.2035119100
Horii T, Kimura M, Morita S, Nagao Y, Hatada I (2008) Loss of genomic imprinting in mouse parthenogenetic embryonic stem cells. Stem Cells 26:79–88. https://doi.org/10.1634/stemcells.2006-0635
Pannetier M, Feil R (2007) Epigenetic stability of embryonic stem cells and developmental potential. Trends Biotechnol 25:556–562. https://doi.org/10.1016/j.tibtech.2007.09.003
Hajkova P et al (2002) Epigenetic reprogramming in mouse primordial germ cells. Mech Dev 117:15–23
Shovlin TC, Durcova-Hills G, Surani A, McLaren A (2008) Heterogeneity in imprinted methylation patterns of pluripotent embryonic germ cells derived from pre-migratory mouse germ cells. Dev Biol 313:674–681. https://doi.org/10.1016/j.ydbio.2007.11.007
Lopes S et al (2003) Epigenetic modifications in an imprinting cluster are controlled by a hierarchy of DMRs suggesting long-range chromatin interactions. Hum Mol Genet 12:295–305. https://doi.org/10.1093/hmg/ddg022
Kobayashi H et al (2006) Bisulfite sequencing and dinucleotide content analysis of 15 imprinted mouse differentially methylated regions (DMRs): paternally methylated DMRs contain less CpGs than maternally methylated DMRs. Cytogenet Genome Res 113:130–137. https://doi.org/10.1159/000090824
Mierzejewska K et al (2013) Genome-wide analysis of murine bone marrowderived very small embryonic-like stem cells reveals that mitogenic growth factor signaling pathways play a crucial role in the quiescence and ageing of these cells. Int J Mol Med 32:281–290. https://doi.org/10.3892/ijmm.2013.1389
Maj M et al (2015) The cell cycle- and insulin-signaling-inhibiting miRNA expression pattern of very small embryonic-like stem cells contributes to their quiescent state. Exp Biol Med (Maywood) 240:1107–1111. https://doi.org/10.1177/1535370215584940
Keniry A et al (2012) The H19 lincRNA is a developmental reservoir of miR-675 that suppresses growth and Igf1r. Nat Cell Biol 14:659–665. https://doi.org/10.1038/ncb2521
Tarnowski M et al (2015) 5Azacytidine inhibits human rhabdomyosarcoma cell growth by downregulating insulinlike growth factor 2 expression and reactivating the H19 gene product miR675, which negatively affects insulinlike growth factors and insulin signaling. Int J Oncol 46:2241–2250. https://doi.org/10.3892/ijo.2015.2906
Ge Y, Sun Y, Chen J (2011) IGF-II is regulated by microRNA-125b in skeletal myogenesis. J Cell Biol 192:69–81. https://doi.org/10.1083/jcb.201007165
Ma N, Zhou L, Zhang Y, Jiang Y, Gao X (2014) Intragenic microRNA and long non-coding RNA: novel potential regulator of IGF2-H19 imprinting region. Evol Dev 16:1–2. https://doi.org/10.1111/ede.12057
Ratajczak MZ et al (2012) Very small embryonic/epiblast-like stem cells (VSELs) and their potential role in aging and organ rejuvenation--an update and comparison to other primitive small stem cells isolated from adult tissues. Aging (Albany NY) 4:235–246. https://doi.org/10.18632/aging.100449
Ratajczak J et al (2011) Higher number of stem cells in the bone marrow of circulating low Igf-1 level Laron dwarf mice--novel view on Igf-1, stem cells and aging. Leukemia 25:729–733. https://doi.org/10.1038/leu.2010.314
Kucia M et al (2013) The negative effect of prolonged somatotrophic/insulin signaling on an adult bone marrow-residing population of pluripotent very small embryonic-like stem cells (VSELs). Age (Dordr) 35:315–330. https://doi.org/10.1007/s11357-011-9364-8
Kucia M et al (2011) Reduced number of VSELs in the bone marrow of growth hormone transgenic mice indicates that chronically elevated Igf1 level accelerates age-dependent exhaustion of pluripotent stem cell pool: a novel view on aging. Leukemia 25:1370–1374. https://doi.org/10.1038/leu.2011.98
Bartke A, Westbrook R, Sun L, Ratajczak M (2013) Links between growth hormone and aging. Endokrynol Pol 64:46–52
Grymula K et al (2014) Positive effects of prolonged caloric restriction on the population of very small embryonic-like stem cells - hematopoietic and ovarian implications. J Ovarian Res 7:68. https://doi.org/10.1186/1757-2215-7-68
Marycz K et al (2016) Endurance exercise mobilizes developmentally early stem cells into peripheral blood and increases their number in bone marrow: implications for tissue regeneration. Stem Cells Int:5756901. https://doi.org/10.1155/2016/5756901
Bazgir B, Fathi R, Rezazadeh Valojerdi M, Mozdziak P, Asgari A (2017) Satellite cells contribution to exercise mediated muscle hypertrophy and repair. Cell J 18:473–484
Zhao H, Halicka HD, Li J, Darzynkiewicz Z (2013) Berberine suppresses gero-conversion from cell cycle arrest to senescence. Aging (Albany NY) 5:623–636. https://doi.org/10.18632/aging.100593
Zhang QS et al (2015) The Sirt1 activator SRT3025 expands hematopoietic stem and progenitor cells and improves hematopoiesis in Fanconi anemia mice. Stem Cell Res 15:130–140. https://doi.org/10.1016/j.scr.2015.05.007
Peled T et al (2012) Nicotinamide, a SIRT1 inhibitor, inhibits differentiation and facilitates expansion of hematopoietic progenitor cells with enhanced bone marrow homing and engraftment. Exp Hematol 40:342–355 e341. https://doi.org/10.1016/j.exphem.2011.12.005
Chaurasia P, Gajzer DC, Schaniel C, D'Souza S, Hoffman R (2014) Epigenetic reprogramming induces the expansion of cord blood stem cells. J Clin Invest 124:2378–2395. https://doi.org/10.1172/JCI70313
Horwitz ME et al (2014) Umbilical cord blood expansion with nicotinamide provides long-term multilineage engraftment. J Clin Invest 124:3121–3128. https://doi.org/10.1172/JCI74556
Broxmeyer H, Inhibiting E (2014) HDAC for human hematopoietic stem cell expansion. J Clin Invest 124:2365–2368. https://doi.org/10.1172/JCI75803
Masoro EJ (2005) Overview of caloric restriction and ageing. Mech Ageing Dev 126:913–922. https://doi.org/10.1016/j.mad.2005.03.012
Osborne TB, Mendel LB, Ferry EL (1917) The effect of retardation of growth upon the breeding period and duration of life of rats. Science 45:294–295. https://doi.org/10.1126/science.45.1160.294
McCay CM, Crowell MF, Maynard LA (1935) The effect of retarded growth upon the length of life span and upon the ultimate body size: one figure. J Nutr 10:63–79
Fontana L, Klein S (2007) Aging, adiposity, and calorie restriction. JAMA 297:986–994. https://doi.org/10.1001/jama.297.9.986
Weindruch R, Sohal RS (1997) Seminars in medicine of the Beth Israel Deaconess Medical Center. Caloric intake and aging. N Engl J Med 337:986–994. https://doi.org/10.1056/NEJM199710023371407
Weindruch R, Naylor PH, Goldstein AL, Walford RL (1988) Influences of aging and dietary restriction on serum thymosin alpha 1 levels in mice. J Gerontol 43:B40–B42
Weindruch R, Walford RL (1982) Dietary restriction in mice beginning at 1 year of age: effect on life-span and spontaneous cancer incidence. Science 215:1415–1418. https://doi.org/10.1126/science.7063854
Anderson RM, Weindruch R (2010) Metabolic reprogramming, caloric restriction and aging. Trends Endocrinol Metab 21:134–141. https://doi.org/10.1016/j.tem.2009.11.005
Harper JM, Leathers CW, Austad SN (2006) Does caloric restriction extend life in wild mice? Aging Cell 5:441–449. https://doi.org/10.1111/j.1474-9726.2006.00236.x
Gallinetti J, Harputlugil E, Mitchell JR (2013) Amino acid sensing in dietary-restriction-mediated longevity: roles of signal-transducing kinases GCN2 and TOR. Biochem J 449:1–10. https://doi.org/10.1042/BJ20121098
Miller RA et al (2005) Methionine-deficient diet extends mouse lifespan, slows immune and lens aging, alters glucose, T4, IGF-I and insulin levels, and increases hepatocyte MIF levels and stress resistance. Aging Cell 4:119–125. https://doi.org/10.1111/j.1474-9726.2005.00152.x
Maeda H et al (1985) Nutritional influences on aging of Fischer 344 rats: II. Pathology. J Gerontol 40:671–688
Bronson RT, Lipman RD (1991) Reduction in rate of occurrence of age related lesions in dietary restricted laboratory mice. Growth Dev Aging 55:169–184
Hursting SD, Lavigne JA, Berrigan D, Perkins SN, Barrett JC (2003) Calorie restriction, aging, and cancer prevention: mechanisms of action and applicability to humans. Annu Rev Med 54:131–152. https://doi.org/10.1146/annurev.med.54.101601.152156
Heilbronn LK et al (2006) Effect of 6-month calorie restriction on biomarkers of longevity, metabolic adaptation, and oxidative stress in overweight individuals: a randomized controlled trial. JAMA 295:1539–1548. https://doi.org/10.1001/jama.295.13.1539
Larson-Meyer DE et al (2006) Effect of calorie restriction with or without exercise on insulin sensitivity, beta-cell function, fat cell size, and ectopic lipid in overweight subjects. Diabetes Care 29:1337–1344. https://doi.org/10.2337/dc05-2565
Redman LM et al (2007) Effect of calorie restriction with or without exercise on body composition and fat distribution. J Clin Endocrinol Metab 92:865–872. https://doi.org/10.1210/jc.2006-2184
Racette SB et al (2006) One year of caloric restriction in humans: feasibility and effects on body composition and abdominal adipose tissue. J Gerontol A Biol Sci Med Sci 61:943–950. https://doi.org/10.1093/gerona/61.9.943
Weiss EP et al (2006) Improvements in glucose tolerance and insulin action induced by increasing energy expenditure or decreasing energy intake: a randomized controlled trial. Am J Clin Nutr 84:1033–1042. https://doi.org/10.1093/ajcn/84.5.1033
Demetrius L (2006) Aging in mouse and human systems: a comparative study. Ann N Y Acad Sci 1067:66–82. https://doi.org/10.1196/annals.1354.010
Phelan JP, Rose MR (2006) Caloric restriction increases longevity substantially only when the reaction norm is steep. Biogerontology 7:161–164. https://doi.org/10.1007/s10522-006-9005-2
Kennedy MA, Rakoczy SG, Brown-Borg HM (2003) Long-living Ames dwarf mouse hepatocytes readily undergo apoptosis. Exp Gerontol 38:997–1008
Buckwalter MS, Katz RW, Camper SA (1991) Localization of the panhypopituitary dwarf mutation (df) on mouse chromosome 11 in an intersubspecific backcross. Genomics 10:515–526
Murakami S (2006) Stress resistance in long-lived mouse models. Exp Gerontol 41:1014–1019. https://doi.org/10.1016/j.exger.2006.06.061
Ikeno Y, Bronson RT, Hubbard GB, Lee S, Bartke A (2003) Delayed occurrence of fatal neoplastic diseases in ames dwarf mice: correlation to extended longevity. J Gerontol A Biol Sci Med Sci 58:291–296. https://doi.org/10.1093/gerona/58.4.b291
Vergara M, Smith-Wheelock M, Harper JM, Sigler R, Miller RA (2004) Hormone-treated snell dwarf mice regain fertility but remain long lived and disease resistant. J Gerontol A Biol Sci Med Sci 59:1244–1250. https://doi.org/10.1093/gerona/59.12.1244
Majeed N et al (2005) A germ line mutation that delays prostate cancer progression and prolongs survival in a murine prostate cancer model. Oncogene 24:4736–4740. https://doi.org/10.1038/sj.onc.1208572
Amador-Noguez D et al (2007) Alterations in xenobiotic metabolism in the long-lived Little mice. Aging Cell 6:453–470. https://doi.org/10.1111/j.1474-9726.2007.00300.x
Berryman DE et al (2004) Comparing adiposity profiles in three mouse models with altered GH signaling. Growth Horm IGF Res 14:309–318. https://doi.org/10.1016/j.ghir.2004.02.005
Berryman DE et al (2010) Two-year body composition analyses of long-lived GHR null mice. J Gerontol A Biol Sci Med Sci 65:31–40. https://doi.org/10.1093/gerona/glp175
Wang M, Miller RA (2012) Augmented autophagy pathways and MTOR modulation in fibroblasts from long-lived mutant mice. Autophagy 8:1273–1274. https://doi.org/10.4161/auto.20917
Conover CA, Bale LK (2007) Loss of pregnancy-associated plasma protein a extends lifespan in mice. Aging Cell 6:727–729. https://doi.org/10.1111/j.1474-9726.2007.00328.x
Bartke A (2003) Can growth hormone (GH) accelerate aging? Evidence from GH-transgenic mice. Neuroendocrinology 78:210–216. https://doi.org/10.1159/000073704
Palmer AJ et al (2009) Age-related changes in body composition of bovine growth hormone transgenic mice. Endocrinology 150:1353–1360. https://doi.org/10.1210/en.2008-1199
Kurosu H et al (2005) Suppression of aging in mice by the hormone Klotho. Science 309:1829–1833. https://doi.org/10.1126/science.1112766
Morris JZ, Tissenbaum HA, Ruvkun G (1996) A phosphatidylinositol-3-OH kinase family member regulating longevity and diapause in Caenorhabditis elegans. Nature 382:536–539. https://doi.org/10.1038/382536a0
Lee SS, Kennedy S (2003) Tolonen, A. C. & Ruvkun, G. DAF-16 target genes that control C. elegans life-span and metabolism. Science 300:644–647. https://doi.org/10.1126/science.1083614
Oh SW et al (2006) Identification of direct DAF-16 targets controlling longevity, metabolism and diapause by chromatin immunoprecipitation. Nat Genet 38:251–257. https://doi.org/10.1038/ng1723
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Kucia, M., Ratajczak, M.Z. (2019). Plausible Links Between Metabolic Networks, Stem Cells, and Longevity. In: Ratajczak, M. (eds) Stem Cells. Advances in Experimental Medicine and Biology, vol 1201. Springer, Cham. https://doi.org/10.1007/978-3-030-31206-0_15
Download citation
DOI: https://doi.org/10.1007/978-3-030-31206-0_15
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-31205-3
Online ISBN: 978-3-030-31206-0
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)